Notice of Change to Key Dates for RFA-NS-17-024 "Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)"

Notice Number: NOT-NS-17-035

Key Dates
Release Date: July 18, 2017

Related Announcements
RFA-NS-17-024

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to change the Key Dates for RFA-NS-17-024, "Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)".

Part 1. Overview Information

Key Dates

Currently reads:

Open Date (Earliest Submission Date)

August 1, 2017

Letter of Intent Due Date

August 1, 2017

Application Due Date(s)

September 1, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

No late applications will be accepted for the Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

September 2, 2017

Modified to read:

Open Date (Earliest Submission Date)

August 26, 2017

Letter of Intent Due Date

August 26, 2017

Application Due Date(s)

September 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

No late applications will be accepted for the Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

September 27, 2017

 

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Codrin Lungu, MD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135
Email: lunguci@ninds.nih.gov